New diabetes study shows two drugs outperforming others

A large-scale clinical trial comparing four common drugs used to treat Type 2 diabetes found that two of the drugs performed “modestly better” than the others. The study is especially important, as 90% to 95% of the 37 million Americans living with diabetes have Type 2. The results can now be used in the decision-making process for each individual patient in light of their levels of glucose control, how well the medications are tolerated, and the person’s other health considerations.

Read Long Article

Scroll to Top